HIV biological variability unveiled: Frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use

AIDS

Volumn 17, Issue 18, 2003, Pages 2561-2569

  Karlsson, Ingrid ^a   Antonsson, Liselotte ^a   Shi, Yu ^b   Karlsson, Anders ^c   Albert, Jan ^b   Leitner, Thomas ^d   Olde, Björn ^a   Owman, Christer ^a   Fenyö, Eva Maria ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

CCR5 CXCR4 chimeric receptors; CD4 T cell decline; Evolution of coreceptor use; HIV pathogenesis; Sequential HIV isolates

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2B; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CHIMERIC PROTEIN; DIDANOSINE; FC RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EVOLUTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONOTHERAPY; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CELL LINE; DIDANOSINE; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV; RECOMBINANT FUSION PROTEINS; VARIATION (GENETICS); VIRUS REPLICATION; ZIDOVUDINE;

EID: 1642423935     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200312050-00003     Document Type: Article

References (36)

1. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997, 71:7478-7487.
2. Scarlatti G, Tresoldi E, Bjorndal A, Fredriksson R, Colognesi C, Deng HK, et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 1997, 3:1259-1265.
3. Fenyo EM. The role of virus biological phenotype in human immunodeficiency virus pathogenesis. AIDS Rev 2001, 3: 157-168.
4. Koot M, Vos AH, Keet RP, de Coede RE, Dercksen MW, Terpstra FG, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
5. Fiore JR, Bjorndal A, Peipke KA, Di Stefano M, Angarano G, Pastore G, et al. The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 1994, 204:297-303.
6. Fiore JR, Buccoliero C, Pezzotti P, Rezza C, Saracino A, Pastore G, et al. HIV-1 disease progression in women: role of the viral phenotype of the HIV-positive steady partner. AIDS 1999, 13:1801-1802.
7. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997, 94:1925-1930.
8. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997, 185:1681-1691.
9. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 1998, 72:5035-5045.
10. Rabin RL, Park MK, Liao F, Swofford R, Stephany D, Farber JM. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol 1999, 162:3840-3850.
11. Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, Schuitemaker H. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci USA 2000, 97:1269-1274.
12. Alfano M, Schmidtmayerova H, Amelia CA, Pushkarsky T, Bukrinsky M. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. J Exp Med 1999, 190:597-605.
13. Weissman D, Rabin RL, Arthos J, Rubbert A, Dybul M, Swofford R, et al. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 1997, 389:981-985.
14. Cicala C, Arthos J, Ruiz M, Vaccarezza M, Rubbert A, Riva A, et al. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. J Immunol 1999, 163:420-426.
15. Arthos J, Rubbert A, Rabin RL, Cicala C, Machado E, Wildt K, et al. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J Virol 2000, 74:6418-6424.
16. Cicala C, Arthos J, Selig SM, Dennis G, Jr, Hosack DA, van Ryk D, et al. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci USA 2002, 99:9380-9385.
17. Karlsson A, Parsmyr K, Aperia K, Sandstrom E, Fenyo EM, Albert J. MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance. J Infect Dis 1994, 170:1367-1375.
18. Scarlatti G, Lombardi V, Plebani A, Principi N, Vegni C, Ferraris G, et al. Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children. AIDS 1991, 5:1173-1178.
19. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
20. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997, 388:296-300.
21. Morner A, Bjorndal A, Albert J, Kewalramani VN, Littman DR, Inoue R, et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 1999, 73: 2343-2349.
22. Olde B, Sabirsh A, Owman C. Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor. J Mol Neurosci 1998, 11:127-134.
23. Sundqvist VA, Albert J, Ohlsson E, Hinkula J, Fenyo EM, Wahren B. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med Virol 1989, 29:170-175.
24. Vodros D, Tscherning-Casper C, Navea L, Schols D, de Clercq E, Fenyo EM. Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay. Virology 2001, 291:1-11.
25. Schols D, Struyf S, van Damme J, Este JA, Henson G, de Clercq E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997, 186: 1383-1388.
26. Shi Y, Albert J, Francis G, Holmes H, Fenyo EM. A new cell line-based neutralization assay for primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2002, 18:957-967.
27. Leitner T, Korovina C, Marquina S, Smolskaya T, Albert J. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant. AIDS Res Hum Retroviruses 1996, 12: 1595-1603.
28. van de Peer Y, de Wachter R. TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Appl Biosci 1994, 10:569-570.
29. Philpott S, Weiser B, Anastos K, Kitchen CM, Robison E, Meyer WA III, et al. Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy. J Clin Invest 2001, 107:431-438.
30. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999, 73:10489-10502.
31. Hughes ES, Bell JE, Simmonds P. Investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env. J Gen Virol 1997, 78: 2871-2882.
32. Donaldson YK, Bell JE, Holmes EC, Hughes ES, Brown HK, Simmonds P. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 1994, 68: 5991-6005.
33. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, Fischer U, et al. Recombination: multiply infected spleen cells in HIV patients. Nature 2002, 418:144.
34. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289:739-745.
35. Berson JF, Doms RW. Structure-function studies of the HIV-1 coreceptors. Semin Immunol 1998, 10:237-248.
36. Pontow S, Ratner L. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors. J Virol 2001, 75:11503-11514.